<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2852</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">AJCC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1000-1000</td>
    </tr>
</table>

<br/><b>Description</b><br/>
The presence of metastatic brain disease at diagnosis is an independent prognostic indicator, and it is used by
Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.

<br/><br/><b>Rationale</b><br/>
The presence of metastatic brain disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.

<br/><br/><b>
  Codes (See the most current version of the <em>Collaborative Stage Data Collection System</em> (<a href="http://cancerstaging.org">http://cancerstaging.org</a>), for rules and site-specific codes and coding structures.) 
</b><br/>
<br/>
  <em>Note:</em> This includes only the brain, not spinal cord or other parts of the central nervous system.
<br/>
